← Back to headlines
Slovenian Company Cosylab Achieves Breakthrough in Cancer Treatment
Slovenian company Cosylab, in collaboration with the Mayo Clinic, has developed its first proprietary clinical product, PlanOne, for cancer treatment, which has already received FDA approval.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
